Managing Neuroleptic Malignant Syndrome: An Evidence-Based Update

<p>How should we approach the management of neuroleptic malignant syndrome? What is the role of bromocriptine, dantrolene, and ECT?<br /> <br /> Faculty: Jim Phelps, M.D.<br /> Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC096"> <strong>Learn more about Premium Membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/publication/quick-take-vol-23-2627?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC096"> <strong>Earn 0.5 CMEs: Quick Take Vol. 23</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/the-neuroleptic-malignant-syndromea-systematic-case-series-analysis-focusing-on-therapy-regimes-and-outcome-2627-4976?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC096"> <strong>The Neuroleptic Malignant Syndrome—A Systematic Case Series Analysis Focusing on Therapy Regimes and Outcome</strong></a></li> </ul>